RE:RE:RE:RE:RE:RE:I agree that financials will do nothing for the share priceSure, DM's covid test kit revenue might stop in the future (we'd all love to see this covid mess behind us), but unfortuately, the virus seems dermined to stick with us, mutating as needed, meaning testing is more likely to fluctuate through the seasons and with variant severity -- we're just coming out of flu season, so testing will slow or stop in some cases like with the NHL, at least until the next flu season.
I totally agree that at some point, this covid money won't matter so much, and it'll be fantastic to see AI rev surpass covid rev. When AI is the dominate source of income, folks will start to see Datametrex as the serious AI contender it's proving to be. Few companies become sucesses overnight, but a gradual ascent is all I need to see to keep my DM shares tucked away. I'm not talking about the stock price, but rather it's the confidence in their AI product that must keep growing. Albeit, it's not happening fast enough for some investors who want returns in weeks or months, but major growth can take years to establlish, and imo it's starting to feel like we're on the cusp of going from being a startup to being a grownup company, reaching puberty with the uplisting ;)